{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:31:36Z","timestamp":1772263896783,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12U8118N"],"award-info":[{"award-number":["12U8118N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00428","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T04:28:56Z","timestamp":1544502536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients"],"prefix":"10.3389","volume":"8","author":[{"given":"Wim","family":"Adriaensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efd","family":"Abdellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"van Henten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonas","family":"Gedamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bewketu","family":"Mengesha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emebet","family":"Adem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Kestens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1128\/CDLI.7.5.832-834.2000","article-title":"Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin","volume":"7","author":"Amirayan-Chevillard","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4314\/ahs.v15i2.5","article-title":"A non-specific biomarker of disease activity in HIV\/AIDS patients from resource-limited environments","volume":"15","author":"Bipath","year":"2015","journal-title":"Afr. Health Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1074-7613(00)80436-7","article-title":"CD40 ligand is required for protective cell-mediated immunity to Leishmania major","volume":"4","author":"Campbell","year":"1996","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/hiv.12206","article-title":"Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients","volume":"16","author":"Casado","year":"2015","journal-title":"HIV Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"143648","DOI":"10.1155\/2013\/143648","article-title":"Utility of serum neopterin and serum IL-2 receptor levels to predict absolute CD4 T lymphocyte count in HIV infected cases","volume":"2013","author":"Chadha","year":"2013","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1128\/IAI.69.5.3255-3263.2001","article-title":"Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages","volume":"69","author":"Chen","year":"2001","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/CDLI.11.4.635-641.2004","article-title":"Targeting CD40L: a promising therapeutic approach","volume":"11","author":"Daoussis","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0141265","DOI":"10.1371\/journal.pone.0141265","article-title":"Soluble CD40 ligand in sera of subjects exposed to Leishmania infantum infection reduces the parasite load in macrophages","volume":"10","author":"de Oliveira","year":"2015","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/1471-2334-13-331","article-title":"High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis","volume":"13","author":"de Oliveira","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/000349803225002499","volume":"97","author":"Desjeux","year":"2003","journal-title":"Leishmania"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","article-title":"Visceral Leishmaniasis and HIV coinfection in East Africa","volume":"8","author":"Diro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"196432","DOI":"10.1155\/2013\/196432","article-title":"Neopterin in diagnosis and monitoring of infectious diseases","volume":"2013","author":"Eisenhut","year":"2013","journal-title":"J. Biomark."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cyto.2016.11.016","article-title":"Serological signatures of clinical cure following successful treatment with sodium stibogluconate in Ethiopian visceral leishmaniasis","volume":"91","author":"Gadisa","year":"2017","journal-title":"Cytokine"},{"key":"B14","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.161.9.4563","article-title":"CD40 ligand\/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge","volume":"161","author":"Gurunathan","year":"1998","journal-title":"J. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1574-695X.2000.tb01408.x","article-title":"Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?","volume":"27","author":"Hamerlinck","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16308","DOI":"10.1038\/srep16308","article-title":"Urinary neopterin, a non-invasive marker of mammalian cellular immune activation, is highly stable under field conditions","volume":"5","author":"Heistermann","year":"2015","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1086\/652750","article-title":"Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy","volume":"201","author":"Kalayjian","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fcimb.2018.00181","article-title":"Macrophage activation marker neopterin: a candidate biomarker for treatment response and relapse in visceral leishmaniasis","volume":"8","author":"Kip","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1189\/jlb.68.3.373","article-title":"The emerging role of CD40 ligand in HIV infection","volume":"68","author":"Kornbluth","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"B20","first-page":"105","article-title":"The importance of sCD40 and sCD40L concentration in patients with chronic HCV infection and HIV co-infection","volume":"5","author":"Lapinski","year":"2014","journal-title":"Przegl. Epidemiol."},{"key":"B21","first-page":"1","article-title":"Chapter 1 - Introduction to Costimulation and Costimulatory Molecules","volume-title":"Developing Costimulatory Molecules for Immunotherapy of Diseases","author":"Manzoor","year":"2015"},{"key":"B22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pt.2006.01.003","article-title":"The conundrum of CD40 function: host protection or disease promotion?","volume":"22","author":"Mathur","year":"2006","journal-title":"Trends Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/QAD.0000000000000698","article-title":"Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection","volume":"29","author":"Miller","year":"2015","journal-title":"AIDS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.4049\/jimmunol.174.8.4916","article-title":"Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis","volume":"174","author":"Murray","year":"2005","journal-title":"J. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1128\/IAI.71.11.6453-6462.2003","article-title":"Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis","volume":"71","author":"Murray","year":"2003","journal-title":"Infect. Immun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e44411","DOI":"10.1371\/journal.pone.0044411","article-title":"Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?","volume":"7","author":"Nyamweya","year":"2012","journal-title":"PLoS ONE"},{"key":"B29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12026-013-8389-8","article-title":"The immunology of Leishmania\/HIV co-infection","volume":"56","author":"Okwor","year":"2013","journal-title":"Immunol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1468-1293.2012.01000.x","article-title":"Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study","volume":"13","author":"Olmo","year":"2012","journal-title":"HIV Med."},{"key":"B31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(88)91317-7","article-title":"Differential diagnosis between non-A, non-B hepatitis and fatty liver by measurement of urinary neopterin","volume":"1","author":"Reibnegger","year":"1988","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit. Vectors"},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2249.1995.tb03849.x","article-title":"Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis","volume":"102","author":"Schriefer","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0144292","DOI":"10.1371\/journal.pone.0144292","article-title":"Plasma levels of neopterin and C-Reactive Protein (CRP) in tuberculosis (TB) with and without HIV coinfection in relation to CD4 cell count","volume":"10","author":"Skogmar","year":"2015","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6825493","DOI":"10.1155\/2017\/6825493","article-title":"HIV as a cause of immune activation and immunosenescence","volume":"2017","author":"Sokoya","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1074-7613(00)80434-3","article-title":"Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection","volume":"4","author":"Soong","year":"1996","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.smim.2009.06.003","article-title":"CD40 and the immune response to parasitic infections","volume":"21","author":"Subauste","year":"2009","journal-title":"Semin. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2009.05.008","article-title":"Neopterin, a prognostic marker in human malignancies","volume":"287","author":"Sucher","year":"2010","journal-title":"Cancer Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e3011","DOI":"10.1371\/journal.pntd.0003011","article-title":"A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?","volume":"8","author":"van Griensven","year":"","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e3023","DOI":"10.1371\/journal.pntd.0003023","article-title":"Visceral leishmaniasis and HIV coinfection: time for concerted action","volume":"8","author":"van Griensven","year":"","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:35:34Z","timestamp":1694478934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":42,"alternative-id":["10.3389\/fcimb.2018.00428"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00428","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"article-number":"428"}}